A leading provider of digital and computational pathology solutions, Proscia has released new study results demonstrating an AI breakthrough in melanoma detection. The new study was conducted at Thomas Jefferson University and the University of Florida, and it was conducted on an uncurated set of 1,422 sequential skin biopsies. The AI was able to correctly identify invasive melanoma and melanoma in situ with a sensitivity of 93% and specificity of 91%. Proscia is also conducting further research into the possible benefits of AI in dermatology, including how it can deliver faster results to patients and improve consistency in the diagnosis of difficult melanoma cases.
New to digital pathology? Learn how whole slide imaging is changing the industry here.